OCUL Stock Analysis Today
Updated Nov 9, 2026 · trends, key levels, insider activity and news
Is OCUL bullish or bearish today?
Daily trend: Downtrend (confirmed) — turns up above $7.75
SEPT signal: Accumulation · Strong Bearish
Research grade: C+ · fair value $13.50 (+210.6%)
OCUL trend by timeframe
| Daily | Downtrend (confirmed) |
|---|---|
| 4 hour | Strong Bearish |
| 1 hour | Bullish |
| 15 min | Strong Bullish |
| 5 min | Strong Bearish |
Trends are calculated from price structure and update during market hours.
OCUL support and resistance levels
Resistance (above)
$6.798 touches
$7.5421 touches
$8.1518 touches
Support (below)
$6.0011 touches
$5.115 touches
$4.066 touches
Upside zones: $10.48 / $11.03 / $11.58
See all levels on the live chart →Insider and institutional activity
Insiders
Sell30-day buys / sells
0 / 930-day net
—Hedge fund holders
229Latest OCUL news and filings
- AnalystH.C. Wainwright
H.C. Wainwright kept its Buy rating on Ocular Therapeutix (OCUL).
- AnalystBenzinga
Needham Keeps Buy Rating on Ocular Therapeutix, $18 Target
Needham repeated its buy rating for Ocular Therapeutix and left its $18 price target unchanged. The analyst firm's stance on the eye care company stays the same.
- AnalystBenzinga
UBS starts Ocular Therapeutix coverage with Buy rating, $14 price target
UBS began covering Ocular Therapeutix and gave the stock a Buy rating. The firm set a price target of $14 per share.
Live OCUL chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is OCUL bullish or bearish today?
OCUL daily trend: Downtrend (confirmed) — turns up above $7.75. SEPT signal: Accumulation (Strong Bearish). Updated Nov 9, 2026.
What is OCUL's trend on each timeframe?
Daily: Downtrend (confirmed); 4 hour: Strong Bearish; 1 hour: Bullish; 15 min: Strong Bullish; 5 min: Strong Bearish.
What are OCUL support and resistance levels?
Support: $6.00, $5.11, $4.06. Resistance: $6.79, $7.54, $8.15. Last price $6.59.
Are insiders buying or selling OCUL?
Insider signal: Sell. Last 30 days: 0 buys, 9 sells. 229 hedge funds hold OCUL.
What is the latest news on OCUL?
Oct 20, 2026: H.C. Wainwright kept its Buy rating on Ocular Therapeutix (OCUL). · Oct 19, 2026: Needham Keeps Buy Rating on Ocular Therapeutix, $18 Target · Oct 12, 2026: UBS starts Ocular Therapeutix coverage with Buy rating, $14 price target